Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

International Journal of Antimicrobial Agents

Volumn 41, Issue 6, 2013, Pages 564-568

  Udy, Andrew A ^a   Covajes, Cecilia ^b   Taccone, Fabio Silvio ^b   Jacobs, Frédérique ^b   Vincent, Jean Louis ^b   Lipman, Jeffrey ^a   Roberts, Jason A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Continuous renal replacement therapy; Critical illness; Pharmacokinetics; Vancomycin

Indexed keywords

VANCOMYCIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLASMA; RENAL REPLACEMENT THERAPY; SEPSIS; VANCOMYCIN;

EID: 84877715742     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.01.018     Document Type: Article

References (26)

1. S. Finfer, R. Bellomo, J. Lipman, C. French, G. Dobb, and J. Myburgh Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units Intensive Care Med 30 2004 589 596
2. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
3. J.A. Roberts, and J. Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851
4. S. Uchino The epidemiology of acute renal failure in the world Curr Opin Crit Care 12 2006 538 543
5. P.G. Metnitz, C.G. Krenn, H. Steltzer, T. Lang, J. Ploder, and K. Lenz Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients Crit Care Med 30 2002 2051 2058
6. M. Oppert, C. Engel, F.M. Brunkhorst, H. Bogatsch, K. Reinhart, and U. Frei Acute renal failure in patients with severe sepsis and septic shock - a significant independent risk factor for mortality: results from the German Prevalence Study Nephrol Dial Transplant 23 2008 904 909
7. J.T. Kielstein, and O. Burkhardt Dosing of antibiotics in critically ill patients undergoing renal replacement therapy Curr Pharm Biotechnol 12 2011 2015 2019
8. D.M. Roberts, J.A. Roberts, M.S. Roberts, X. Liu, P. Nair, and L. Cole Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study Crit Care Med 40 2012 1523 1528
9. G. Choi, C.D. Gomersall, Q. Tian, G.M. Joynt, R. Freebairn, and J. Lipman Principles of antibacterial dosing in continuous renal replacement therapy Crit Care Med 37 2009 2268 2282
10. H. Hanberger, S. Walther, M. Leone, P.S. Barie, J. Rello, and J. Lipman Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study Int J Antimicrob Agents 38 2011 331 335
11. K.M. Ho, and J.O. Robinson Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study Anaesth Intensive Care 37 2009 457 463
12. M.J. Rybak, B.M. Lomaestro, J.C. Rotschafer, R.C. Moellering, W.A. Craig, and M. Billeter Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists Clin Infect Dis 49 2009 325 327
13. K.A. Rodvold, R.A. Blum, J.H. Fischer, H.Z. Zokufa, J.C. Rotschafer, and K.B. Crossley Vancomycin pharmacokinetics in patients with various degrees of renal function Antimicrob Agents Chemother 32 1988 848 852
14. J.A. Roberts, F.S. Taccone, A.A. Udy, J.L. Vincent, F. Jacobs, and J. Lipman Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens Antimicrob Agents Chemother 55 2011 2704 2709
15. W. Chaijamorn, A. Jitsurong, K. Wiwattanawongsa, U. Wanakamanee, and P. Dandecha Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients Int J Antimicrob Agents 38 2011 152 156
16. E.N. Frazee, P.J. Kuper, G.E. Schramm, S.L. Larson, K.B. Kashani, and D.R. Osmon Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations Antimicrob Agents Chemother 56 2012 6181 6185
17. C. Covajes, S. Scolletta, L. Penaccini, E. Ocampos-Martinez, A. Abdelhadii, and M. Beumier Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy Int J Antimicrob Agents 41 2013 261 266
18. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Intensive Care Med 29 2003 530 538
19. P.M. Palevsky Indications and timing of renal replacement therapy in acute kidney injury Crit Care Med 36 4 Suppl. 2008 S224 S228
20. S.L. Beal NONMEM user guides (I-VIII) 1998 University of California at San Francisco San Francisco, CA
21. M.E. DelDot, J. Lipman, and S.E. Tett Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration Br J Clin Pharmacol 58 2004 259 268
22. R. Bellomo, A. Cass, L. Cole, S. Finfer, M. Gallagher, and S. Lo Intensity of continuous renal-replacement therapy in critically ill patients N Engl J Med 361 2009 1627 1638
23. W.L. Macias, B.A. Mueller, and S.K. Scarim Vancomycin pharmacokinetics in acute renal failure: preservation of nonrenal clearance Clin Pharmacol Ther 50 1991 688 694
24. C.J. Karvellas, M.R. Farhat, I. Sajjad, S.S. Mogensen, A.A. Leung, and R. Wald A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis Crit Care 15 2011 R72
25. S. Uchino, N. Fealy, I. Baldwin, H. Morimatsu, and R. Bellomo Continuous is not continuous: the incidence and impact of circuit 'down-time' on uraemic control during continuous veno-venous haemofiltration Intensive Care Med 29 2003 575 578
26. K. Berthoin, E. Ampe, P.M. Tulkens, and S. Carryn Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections Int J Antimicrob Agents 34 2009 555 560